What we do
Belle enables an unprecedented level of digital engagement
among all
participants
in skin health and wellness.
Our skin AI platform identifies more than one thousand skin conditions and
variations including
skin cancer, and measures the severity of autoimmune
and inflammatory conditions such as acne, psoriasis, eczema, vitiligo, and
alopecia areata.
Using smartphone photos taken by patients or providers, Belle delivers an
objective,
easy-to-use system for identifying skin conditions,
and for tracking how they progress and respond to treatments.